Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Teleconference
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by jopatcloon May 09, 2024 3:30pm
98 Views
Post# 36031931

RE:RE:RE:Teleconference

RE:RE:RE:TeleconferenceFUD team on ceo and here see 2 FUDSTERS was active Tuesday 07.
TSX-V closed Tuesday 7 0.245 !!!!
April 30 close 0.21 low 0.205 still up 20% Bart Hendrix post may 06
Exciting Development from Ventripoint Diagnostics Ltd.
Meet Us at AEPC 2024 in Porto:
Discover firsthand how VMS+4.0 is setting new standards in cardiac imaging. We’re excited to demonstrate its capabilities and discuss its impact on the future of cardiology. These features ensure that VMS+4.0 can deliver MRI-quality images and analyzes quickly and reliably, making advanced cardiac care accessible in minutes.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities